• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

OrganoPlate UniFlow Technology

Scalable, gravity-driven unidirectional perfusion flow

for advanced 3D human tissues.

As the first commercially available unidirectional, gravity-driven pumpless flow system for drug discovery and disease research, the OrganoPlate UniFlow addresses challenges in traditional flow systems by enabling physiologically accurate tissue models that replicate natural biological conditions.

Unlike traditional systems that require complex pumps and tubing, this platform offers improved physiological relevance and scalability, laying the groundwork for more advanced tissue models including lung, skin, gut, kidney, liver, and tumor systems.


Speak With an Expert

 

 

Enhancing Biological Accuracy and Relevance

The OrganoPlate UF creates conditions that mimic natural vascular flow, ensuring that biological structures are maintained with minimal shear stress. This precision leads to more realistic tissue behavior.

Key features of OrganoPlate UF technology:

  • Unidirectional Flow: Improves physiological modelling of vasculature for cardiovascular, oncological, and immunological research.
  • Pump-free, Gravity-driven: Gravity-driven flow eliminates external pumps, simplifies operations, and mimics natural unidirectional flow.
  • Scalability Without Compromise: Fully compatible with standard liquid handling and imaging equipment, allowing parallel operation of plates with 32 chips each for efficient analysis of hundreds or thousands of samples, accelerating drug discovery with maintained biological relevance.
  • Stable, Long-term Tissue Stability: Enables extended culture of complex tissues, supporting studies on chronic disease and long-term therapeutic effects.


Get Inspired

Perfusable Vascular Networks

Using OrganoPlate UniFlow technology, MIMETAS scientists developed stable, self-organized vascular networks for studying perfusion, immune responses, and therapeutic effects over extended periods. This intuitive system is ideal for modeling complex tissue systems and disease processes.

Key features:

  • Supports intricate microvascular architecture for detailed biological studies.
  • Ensures long-term morphological stability of vascular structures.
  • Enables immune cell perfusion for immuno-oncology and disease research.
  • Scalable, open-well format simplifies use and supports automation.
  • Compatible with high-throughput workflows for broader applications.

Optimized culture conditions support a stable, perfusable vascular bed for at least 3 weeks.


Airway-on-a-Chip for Respiratory Research

MIMETAS’ Airway-on-a-Chip (AoC) model integrates unidirectional flow and perfusable microvascular networks to replicate the structural and functional complexity of human respiratory airways. This innovative model drives progress in studying respiratory diseases and fibrosis.

Key Features:

  • Unidirectional, gravity-driven flow mimics airway fluid dynamics.
  • 3D architecture includes differentiated bronchial epithelium and microvascular networks.
  • Maintains long-term stability under Air-Liquid Interface (ALI) conditions for up to three weeks.
  • Enables studies on chronic conditions like pulmonary fibrosis.
  • Compatible with high-throughput applications for scaling research efforts.

Applications:

  • Examines ECM remodeling and fibrotic changes induced by fibrosis-related compounds.
  • Evaluates vascular and inflammatory responses for therapeutic testing.


Physiologicaly-relevant brochial tissue architecture with proper epithelium differentiation and organization.

Microvascularized Liver Model for Liver Disease and Drug Research

Leveraging OrganoPlate UF technology, MIMETAS developed a microvascularized liver model that accurately mimics human liver tissue, enabling advanced research into liver function, disease, and drug efficacy.

 

Key Features:

  • 3D perfusable liver culture with organ-specific vascular beds formed by primary hepatocytes and non-parenchymal cells.
  • Immune competence enabled through integration of Kupffer cells for inflammatory studies.
  • Organ-specific functionality, including albumin production and functional vascularization.
  • Long-term stability and reproducibility for studying chronic liver conditions.

Applications:

  • Drug metabolism and toxicity testing, including hepatotoxicity and vascular toxicity.
  • Investigation of immune-mediated injury and inflammatory triggers.
  • Modeling chronic liver diseases such as fibrosis, steatosis, and NAFLD.

Immune-competent microvascularized liver. Video shows perfusion of T-cells through a vascularized bed.

Elevate Your Research with OrganoPlate UF

OrganoPlate UF delivers biologically relevant, scalable, and easy-to-use solutions for advancing drug discovery, studying complex diseases, and testing therapies. This platform enables:

  • Unprecedented Disease Modeling: Capture the complexity of human diseases with unparalleled accuracy, enabling more relevant insights.
  • Predictive Data for Drug Development: Generate robust data on drug efficacy and toxicity, reducing costly failures in later stages.
  • Bridging the Preclinical to Clinical Gap: Achieve biologically relevant results that translate more effectively to clinical outcomes.

Access OrganoPlate UF technology through MIMETAS’ service portfolio and let our experts help you achieve groundbreaking results. Contact us today to explore tailored solutions or accelerate your research pipeline.

 

Speak With an Expert

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all